SLC5A2 and type 2 diabetes mellitus: Key terms included (“SGLT2 inhibitors” OR “empagliflozin” OR “dapagliflozin” OR “canagliflozin” OR “ertugliflozin” OR “sotagliflozin”) AND (“heart failure hospitalization” OR “hospitalization for heart failure”) AND (“type 2 diabetes” OR “T2DM”).